Ping Jihui's team from Nanjing Agricultural University reviewed the virus-host interaction network
The latest review of Nanjing Agricultural University: Virus-host interaction network as a new target for anti-IAV and anti-SARS-CoV-2 drugs
Can RNAi, gene therapy, targeted drugs, etc. open a new chapter in lipid-lowering therapy in the post-statin era?
"Every festive season, you gain three pounds, and after three pounds, you gain another three pounds The "magic drug" statin re-emerges: not only inhibits the progression of a variety of liver diseases, but also reduces the incidence of liver cancer! Comprehensive protein interaction network helps researchers discover drug candidates for the treatment of COVID-19 eLife: A model that can predict the impact of drug interactions on antibiotic resistance EHJ: Another magical drug-statins can not only lower lipids, but also fight cancer! BMJ: Relax-how does the lipid-lowering drug statin perform in primary prevention of cardiovascular disease? The market for blood lipid-lowering drugs has sprinted by 30 billion, with statins leading the market
Surprise! Statins against liver cancer help develop new liver cancer drugs
The Use of Differential Scanning Calorimetry to Study Drug-Membrane Interactions Surprise! Statins against liver cancer help develop new liver cancer drugs An in vitro transcription assay for probing drug-DNA interactions at individual drug sites New anti-inflammatory drugs! Bronger Ingeham terminates clinical development of AOC3 inhibitor BI1467335: there is a risk of drug interaction! The meeting previewed I "drug combustion" Kaidong - 2020 biopharmaceutical production and integration interactive forum. (Interactive) Botten shares: 108 workshop can produce innovative drug GMP intermediates The first oral non statins cholesterol lowering drug in recent 20 years! Esperion's first ACL inhibitor, nexletol, has been approved by the US FDA! FASEB J: "statins" -- how can lipid lowering drugs cause muscle pain? Major milestones in cardiovascular prevention! "Fish oil" vascepa was approved as the first drug Clin pharmaceutical her: Alert! Drug interactions can cause hypotension! Time of Update: 2022-01-08
Child-PughA retrospective, population-based cohort study of primary sclerosing cholangitis (PSC) patients with inflammatory bowel disease showed that the use of statins was associated with all-cause mortality and reduced death or liver transplantation .
Time of Update: 2021-11-12
Researchers from the University of Helsinki and the University of Eastern Finland first searched for suitable drug targets and reusable drugs, and finally discovered six antiviral effects against SARS-CoV-2 Candidate drugs .
Time of Update: 2021-08-04
This research can help doctors optimize the choice, timing, dosage and sequence of antibiotics used to treat common infections, and help curb the growing threat of antibiotic resistance
Time of Update: 2021-08-01
>Heart failure (HF) and cancer are two major public health challenges worldwide .
Time of Update: 2021-07-27
However, recent guidelines recommend the wider use of statins in primary prevention, so that a large number of low-risk CVD populations are eligible for treatment and face the risk of adverse reactions .
Time of Update: 2021-02-08
, will lead to a major disaster. statins: the main force of blood lipid-lowering drugs There are many drugs for the treatment of hyperlipidemia, of which statins have a very good "risk-benefit ratio". In addition, the global popular variety
Time of Update: 2021-01-06
these studies have shown that statin use can help improve HBV and HCV-related hepatocellular carcinoma (HCC).
Time of Update: 2021-01-04
Differential-scanning calorimetry is a useful technique to study the interdigitation effect of a drug by monitoring Δ H changes.
Time of Update: 2020-12-12
these studies have shown that statin use can help improve HBV and HCV-related hepatocellular carcinoma (HCC).
Time of Update: 2020-11-21
An in vitro transcription assay of drug- DNA interactions has been described and is based largely on the stable lac UV5-initiated transcription complex.
Time of Update: 2020-09-27
September 08, 2020 // -- Boehringer Ingelheim and Pharmaxis recently jointly announced the termination of the development of BI1467335 for the treatment of moderate to non-proliferative diabetic retinal lesions (NPDR).
Time of Update: 2020-09-05
Contractors: Kaidong High-tech Industrial Development Zone Management Committee, Wise Pharmaceutical Jiangsu Co., Ltd., Huaxing Capital Holdings Co., Ltd., Fahrenheit Kangyuan Pharmaceutical Technology Co., Ltd. Co-technology Media: Easy Enterprise
Time of Update: 2020-05-13
(Interactive) Botten shares : 108 workshop can produce new drugs GMP intermediates source: Panorama author: 2014-08-19 23:20:15 font: CICC Online Weibo WeChat plus
Time of Update: 2020-02-23
The US Food and Drug Administration (FDA) has approved a new cholesterol lowering drug, nexletol (bempedoic), according to esperion therapeutics Acid, tablet), an oral, once-a-day
Time of Update: 2020-02-12
kiemer and her team found the real cause of muscle pain in patients taking statins: a protein called gilz has an important role.
Time of Update: 2020-01-08
Author: tomato HLS therapeutics is a pharmaceutical company specializing in the central nervous system and cardiovascular market
Recently, the company announced Time of Update: 2019-04-15
Co prescription of strong CYP1A2 inhibitors and the risk of tizanidine associated hypertension: a retrospective cohort study, clinical pharmacology & Therapeutics (2018).
Welcome to ECHEMI
